TITLE

FORMULATION AND IN VITRO EVALUTION OF DIACEREIN LOADED NIOSOMES

AUTHOR(S)
ZAKI, RANDA M.; ALI, ADEL A.; MENSHAWE, SHAHIRA F. EL; BARY, AHMED ABDEL
PUB. DATE
April 2014
SOURCE
International Journal of Pharmacy & Pharmaceutical Sciences;2014 Supplement 2, p515
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Diacerein is poorly water soluble non steroidal anti-inflammatory drug belongs to BCS class II with low oral bioavailability. This research aimed towards formulation and evaluation of successful diacerein loaded niosomes in order to improve dissolution and hence its oral bioavailability. Methods: Eight formulations (N1-N8) were prepared by thin film hydration method using different ratios of cholesterol to non ionic surfactant (Span 20 and 60) 1:2 and 1:3. The effect of the composition change of surfactant and cholesterol on the properties such as encapsulation efficiency, particle size and drug release were studied. Also the effect of the presence of 0.5% (w/w) sodium deoxycholate as co surfactant was evaluated. Results: The prepared niosomes were in the size range of 0.5-2.6 um. The order of encapsulation efficiency increases with increase in concentration of Span 60. In vitro release study on diacerein niosomes indicates better release profile compared to free diacerein and 93.24% release at 60 min for formulation N8 prepared with cholesterol: Span 20 (1:3) and 0.5% (w/w) sodium deoxycholate. Conclusion: It was concluded that it is possible to enhance solubility and ultimately improve bioavailability of the drug by this promising approach.
ACCESSION #
95530833

 

Related Articles

  • HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1. Yuki Iwayanagi; Tappei Takada; Hiroshi Suzuki // Pharmaceutical Research;May2008, Vol. 25 Issue 5, p1134 

    Abstract Purpose  Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for...

  • Fat Loss Depends on Energy Deficit Only, Independently of the Method for Weight Loss. Strasser, B.; Spreitzer, A.; Haber, P. // Annals of Nutrition & Metabolism;Sep2007, Vol. 51 Issue 5, p428 

    Background: This study was designed to compare the effects of 2 different but isocaloric fat reduction programs with the same amount of energy deficit – diet alone or diet combined with aerobic training – on body composition, lipid profile and cardiorespiratory fitness in non- or...

  • Hypocholesterolemic Effects of the LDL Receptor Gene Transcriptional Upregulator CP-230821. Shimokawa, Teruhiko; Goto, Shoichiro; Ida, Motoko; Goto, Masahide; Nishijima, Satomi; Kodama, Tatsuhiko // Journal of Biochemistry;1998, Vol. 123 Issue 4, p596 

    CP-230821 is a novel, potent LDL receptor gene transcriptional upregulator which decreases total plasma cholesterol level. Interestingly, this plasma LDL decrease does not alter hepatic lipid contents. A series of experiments was undertaken to study the molecular biology of this phenomenon....

  • Synthesis and molecular docking studies of certain chalcones of benzimidzole. Chandran, Meena // Journal of Pharmacy Research;2012, Vol. 5 Issue 1, p324 

    Molecular docking is routinely used for understanding drug-receptor interaction in modern drug design. In the present work involved the synthesis of three different chalcones of benzimidazole by three steps. Initially by using a o-phenylenediamine and lactic acid as the starting materials for...

  • Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan. Andiara Schwingel; Wojtek Chodzko-Zajko; Ryosuke Shigematsu; Christopher Erb; Simone Souza; Tomoaki Matsuo; Suely Marie // European Journal of Epidemiology;Jan2007, Vol. 22 Issue 1, p33 

    Abstract??Blood lipid levels are determined by a combination of genetic and environmental factors. Higher than average values of high-density lipoprotein cholesterol (HDL-cholesterol) have been observed in people of Japanese ethnicity. The aim of this study was to investigate whether Japanese...

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. Vincent Soriano; Pilar García-Gasco; Eugenia Vispo; Andrés Ruiz-Sancho; Francisco Blanco; Luz Martín-Carbonero; Sonia Rodríguez-Novoa; Judit Morello; Carmen de Mendoza; Pablo Rivas; Pablo Barreiro; Juan González-Lahoz // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p200 

    : Background Atazanavir seems to be a protease inhibitor (PI) with a more favourable metabolic profile. Information regarding the potential benefit of replacing lopinavir/ritonavir by atazanavir in HIV-infected patients with prolonged viral suppression is scarce. If proved, this strategy could...

  • Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect. Andrew Campbell; Samuel Chan // Journal of Bioenergetics & Biomembranes;Jun2008, Vol. 40 Issue 3, p193 

    Abstract  Normal cells of aerobic organisms synthesize the energy they require in the form of ATP via the process of oxidative phosphorylation. This complex system resides in the mitochondria of cells and utilizes oxygen to produce a majority of cellular ATP. However, in most tumors,...

  • Do we need lipid clinics? Shifting the balance between secondary and primary care. Stuart, W; Smellie, A // Annals of Clinical Biochemistry;Nov2005, Vol. 42 Issue 6, p463 

    Background: Increasing activity in cholesterol lowering is placing increasing demands on lipid clinics to be able to cope with the increase in demand. A combination of interventions has been used to improve laboratory testing, focus interpretative results and provide educational and advisory...

  • False negative results in the Roche assay for HDL-cholesterol. Bakker, Andries J; Zijlstra, Appie; Leemhuis, Marten P // Annals of Clinical Biochemistry;Sep2003, Vol. 40 Issue 5, p572 

    Measurement of HDL-cholesterol is important in the risk evaluation of cardiovascular disease. Recently, we encountered a 61-year-old man with a negative result for HDL-cholesterol using the Roche assay. Further analysis revealed that this patient had a monoclonal Ig type IgMκ, with an...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics